Vanguard Group’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$8.37M Sell
8,851,036
-706,139
-7% -$668K ﹤0.01% 3003
2025
Q1
$4.41M Sell
9,557,175
-324,553
-3% -$150K ﹤0.01% 3228
2024
Q4
$7.3M Buy
9,881,728
+1,790,630
+22% +$1.32M ﹤0.01% 3109
2024
Q3
$12.7M Buy
8,091,098
+415,973
+5% +$653K ﹤0.01% 2838
2024
Q2
$12.9M Buy
7,675,125
+1,273,900
+20% +$2.14M ﹤0.01% 2777
2024
Q1
$15.4M Buy
6,401,225
+420,854
+7% +$1.01M ﹤0.01% 2724
2023
Q4
$9.15M Sell
5,980,371
-419,840
-7% -$642K ﹤0.01% 2994
2023
Q3
$6.98M Sell
6,400,211
-56,741
-0.9% -$61.8K ﹤0.01% 3104
2023
Q2
$14.8M Buy
6,456,952
+1,157,572
+22% +$2.65M ﹤0.01% 2731
2023
Q1
$12.9M Buy
5,299,380
+43,032
+0.8% +$105K ﹤0.01% 2800
2022
Q4
$10M Buy
5,256,348
+60
+0% +$115 ﹤0.01% 2946
2022
Q3
$12.6M Buy
5,256,288
+1,334,318
+34% +$3.2M ﹤0.01% 2839
2022
Q2
$7.3M Sell
3,921,970
-234,266
-6% -$436K ﹤0.01% 3165
2022
Q1
$8.69M Buy
4,156,236
+4,484
+0.1% +$9.37K ﹤0.01% 3229
2021
Q4
$16.4M Buy
4,151,752
+166,572
+4% +$656K ﹤0.01% 2948
2021
Q3
$19.2M Buy
3,985,180
+15,191
+0.4% +$73.1K ﹤0.01% 2887
2021
Q2
$18.2M Buy
3,969,989
+11,142
+0.3% +$51.1K ﹤0.01% 2898
2021
Q1
$23.2M Buy
3,958,847
+434,773
+12% +$2.55M ﹤0.01% 2712
2020
Q4
$12.1M Buy
3,524,074
+678,433
+24% +$2.32M ﹤0.01% 2896
2020
Q3
$4.1M Buy
2,845,641
+364,855
+15% +$525K ﹤0.01% 3246
2020
Q2
$4.95M Sell
2,480,786
-719,888
-22% -$1.44M ﹤0.01% 3102
2020
Q1
$6.24M Buy
3,200,674
+224,671
+8% +$438K ﹤0.01% 2856
2019
Q4
$12.4M Sell
2,976,003
-85,986
-3% -$357K ﹤0.01% 2756
2019
Q3
$9.22M Sell
3,061,989
-1,178,122
-28% -$3.55M ﹤0.01% 2855
2019
Q2
$26.7M Buy
4,240,111
+319,382
+8% +$2.01M ﹤0.01% 2372
2019
Q1
$21.8M Buy
3,920,729
+935,567
+31% +$5.2M ﹤0.01% 2467
2018
Q4
$19.8M Sell
2,985,162
-849,604
-22% -$5.64M ﹤0.01% 2441
2018
Q3
$40.9M Buy
3,834,766
+72,640
+2% +$775K ﹤0.01% 2244
2018
Q2
$45.1M Buy
3,762,126
+19,242
+0.5% +$231K ﹤0.01% 2171
2018
Q1
$32.1M Buy
3,742,884
+102,959
+3% +$882K ﹤0.01% 2308
2017
Q4
$36M Buy
3,639,925
+83,164
+2% +$822K ﹤0.01% 2230
2017
Q3
$43.7M Sell
3,556,761
-151,486
-4% -$1.86M ﹤0.01% 2102
2017
Q2
$61M Sell
3,708,247
-460,054
-11% -$7.57M ﹤0.01% 1922
2017
Q1
$59.8M Buy
4,168,301
+585,222
+16% +$8.39M ﹤0.01% 1920
2016
Q4
$49.6M Buy
3,583,079
+169,430
+5% +$2.34M ﹤0.01% 1981
2016
Q3
$61.7M Buy
3,413,649
+46,836
+1% +$846K ﹤0.01% 1839
2016
Q2
$48.3M Buy
3,366,813
+302,929
+10% +$4.35M ﹤0.01% 1922
2016
Q1
$36.6M Buy
3,063,884
+88,668
+3% +$1.06M ﹤0.01% 2008
2015
Q4
$39.6M Buy
2,975,216
+65,134
+2% +$867K ﹤0.01% 1997
2015
Q3
$31.3M Buy
2,910,082
+54,453
+2% +$585K ﹤0.01% 2084
2015
Q2
$23M Buy
2,855,629
+132,816
+5% +$1.07M ﹤0.01% 2293
2015
Q1
$18M Buy
2,722,813
+173,969
+7% +$1.15M ﹤0.01% 2370
2014
Q4
$16.2M Buy
2,548,844
+443,393
+21% +$2.82M ﹤0.01% 2328
2014
Q3
$20.8M Buy
2,105,451
+17,453
+0.8% +$172K ﹤0.01% 2186
2014
Q2
$23.5M Buy
2,087,998
+93,579
+5% +$1.05M ﹤0.01% 2155
2014
Q1
$24.2M Buy
1,994,419
+86,809
+5% +$1.05M ﹤0.01% 2120
2013
Q4
$24M Buy
1,907,610
+80,805
+4% +$1.02M ﹤0.01% 2101
2013
Q3
$30.3M Sell
1,826,805
-275,709
-13% -$4.57M ﹤0.01% 1968
2013
Q2
$31.9M Buy
+2,102,514
New +$31.9M ﹤0.01% 1885